Study of genotype/phenotype relationships involving the Wilms' tumor (
WT) gene, WT1, in WI patients has provided insights into the function
of the WT1 protein, a transcriptional regulator, and has suggested pos
sible mutational mechanisms important in the etiology of WT. for examp
le, the identification of deletion/insertion mutations in the first ex
on implicates a deletion hotspot consensus sequence in the etiology of
these mutations. The disproportionate number of WT/aniridia patients
with such mutations further suggest that this genetic mechanism may be
enhanced by the hemizygous state. WT1 mutations are observed througho
ut the gene and, as predicted by the two-hit mutational model, germlin
e mutations predominantly occur in patients with congenital genitourin
ary (CU) anomalies and/or bilateral disease. The presence of hemizygou
s mutations in tumors from individuals with germline 11p13 deletions e
ncompassing WT1 supports the hypothesis that inactivation of both WT1
alleles is important in tumorigenesis. Analyses of WT1 mutations in in
dividuals with WT-associated Drash syndrome and WT patients with CU an
omalies in the absence of Drash syndrome indicate that Drash patients
almost invariably carry germline missense mutations in the zinc finger
domains whereas WT/GU patients carry germline mutations that delete t
he WT1 gene or encode truncated proteins. These data suggest a functio
nal difference between mutant WT1 protein carrying a single amino acid
substitution versus mutant WT1 protein that is grossly truncated or W
T1 haploinsufficiency. These and other genotype/phentotype correlation
s in WT patients will be discussed in more detail. (C) 1996 Wiley-Liss
, Inc.